Ethanol pharmacokinetics in neonates and infants

Elizabeth Marek, Walter K Kraft, Elizabeth Marek, Walter K Kraft

Abstract

Introduction: Ethanol has been used for years in neonatal and infant liquid medications, yet the pharmacokinetics, pharmacodynamics, and safety of ethanol in this vulnerable population have not been well characterized. The purpose of this review is to raise awareness of ethanol use as an excipient in neonatal and infant medications and to provide insight, based on the available evidence, into clearance rates of ethanol in babies. We also discuss ethanol pharmacokinetics in adults, theoretical pharmacokinetic changes in neonates and infants as it may apply to ethanol disposition, and case reports involving ethanol exposure in neonates and infants.

Materials and methods: This study was a narrative review in which relevant papers were selected using databases and scientific search engines such as PubMed with the key words ethanol, infant, and newborn infant.

Results: It remains unclear what ethanol exposure is safe for neonates and infants. The Food and Drug Administration and American Academy of Pediatrics have both taken action, by either setting limits of ethanol content in over-the-counter medications or by recommending restricted exposure to ethanol-containing pediatric formulations.

Conclusions: Until the short- and long-term health effects of chronic ethanol administration can be further characterized, ethanol-containing medications should be used with caution.

Keywords: Alcohol; Ethanol; Infant; Neonate; Pediatric.

Figures

Figure 1
Figure 1
Ethanol disposition. Physiologic factors in neonates having the potential to affect the absorption, distribution, metabolism, and excretion of ethanol when compared with adults. Red boxes show infant-specific differences compared with adults.

References

    1. Ghosh T.K., Jasti B.R. CRC Press; Boca Raton: 2005. Theory and practice of contemporary pharmaceutics.
    1. Remington: The science and practice of pharmacy. 21st ed. Philadelphia: Lippincott Williams & Wilkins; c2006. Remington, Joseph P. (Joseph Price),1847-1918. and Beringer Paul, eds.
    1. Rayar P., Ratnapalan S. Pediatric ingestions of house hold products containing ethanol: A review. Clin Pediatr (Phila) 2013;52(3):203–209.
    1. Bitunjac K., Saraga M. Alcohol intoxication in pediatric age: Ten-year retrospective study. Croat Med J. 2009;50(2):151–156.
    1. Committee on Drugs Ethanol in liquid preparations intended for children. Pediatrics. 1984;73(3):405–407.
    1. Committee for Human Medicinal Products (CHMP). Questions and answers on ethanol in the context of the revision of the guideline on ‘Excipients in the label and package leaflet of medicinal products for human use’ (CPMP/463/00). . Accessed 08/22, 2014.
    1. Isaac R., Khan I., Langley C. Ethanol intake of paediatric intensive care patients. Archives of Disease in Childhood. 2013;98(6) 11-11.
    1. International Center for Alcohol Policies . International drinking guidelines. International Center for Alcohol Policies; Washington, D.C.: 2003.
    1. Whittaker A., Currie A.E., Turner M.A., Field D.J., Mulla H., Pandya H.C. Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94(4):F236–F240.
    1. United States, Department of Health and Human Services, Department of Agriculture, Dietary Guidelines Advisory Committee . U.S. Dept. of Health and Human Services, U.S. Dept. of Agriculture; [Washington, D.C.]: 2010. Dietary Guidelines for Americans, 2010.
    1. Swift R. Direct measurement of alcohol and its metabolites. Addiction. 2003;98(Suppl 2):73–80.
    1. Jones A.W., Jonsson K.A., Kechagias S. Effect of high-fat, high-protein, and high-carbohydrate meals on the pharmacokinetics of a small dose of ethanol. Br J Clin Pharmacol. 1997;44(6):521–526.
    1. Johnson R.D., Horowitz M., Maddox A.F., Wishart J.M., Shearman D.J. Cigarette smoking and rate of gastric emptying: Effect on alcohol absorption. BMJ. 1991;302(6767):20–23.
    1. Kechagias S., Jonsson K.A., Norlander B., Carlsson B., Jones A.W. Low-dose aspirin decreases blood alcohol concentrations by delaying gastric emptying. Eur J Clin Pharmacol. 1997;53(3-4):241–246.
    1. Klockhoff H., Naslund I., Jones A.W. Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery. Br J Clin Pharmacol. 2002;54(6):587–591.
    1. Edelbroek M.A., Horowitz M., Wishart J.M., Akkermans L.M. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med. 1993;34(4):582–588.
    1. Amir I., Anwar N., Baraona E., Lieber C.S. Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying. Life Sci. 1996;58(6):511–518.
    1. Roine R.P., Gentry R.T., Lim R.T., Jr, Helkkonen E., Salaspuro M., Lieber C.S. Comparison of blood alcohol concentrations after beer and whiskey. Alcohol Clin Exp Res. 1993;17(3):709–711.
    1. Levine B. American Association for Clinical Chemistry; [Washington, D.C.]: 1999. Principles of forensic toxicology.
    1. Frezza M., di Padova C., Pozzato G., Terpin M., Baraona E., Lieber C.S. High blood alcohol levels in women. the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322(2):95–99.
    1. Caballeria J., Frezza M., Hernandez-Munoz R. Gastric origin of the first-pass metabolism of ethanol in humans: Effect of gastrectomy. Gastroenterology. 1989;97(5):1205–1209.
    1. Levitt D.G. PKQuest: Measurement of intestinal absorption and first pass metabolism - application to human ethanol pharmacokinetics. BMC Clin Pharmacol. 2002;2:4.
    1. Norberg A., Jones A.W., Hahn R.G., Gabrielsson J.L. Role of variability in explaining ethanol pharmacokinetics: Research and forensic applications. Clin Pharmacokinet. 2003;42(1):1–31.
    1. Kyle U.G., Genton L., Slosman D.O., Pichard C. Fat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years. Nutrition. 2001;17(7-8):534–541.
    1. Hacker, Miles P, Messer, William S, Bachmann, Kenneth A. Pharmacology principles and practice. Updated 2009.
    1. Cederbaum A.I. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667–685.
    1. Maenhout T.M., De Buyzere M.L., Delanghe J.R. Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta. 2013;415:322–329.
    1. Ingall G.B. Alcohol biomarkers. Clin Lab Med. 2012;32(3):391–406.
    1. Gershman H., Steeper J. Rate of clearance of ethanol from the blood of intoxicated patients in the emergency department. J Emerg Med. 1991;9(5):307–311.
    1. Jones A.W. Ultra-rapid rate of ethanol elimination from blood in drunken drivers with extremely high blood-alcohol concentrations. Int J Legal Med. 2008;122(2):129–134.
    1. Lands W.E. A review of alcohol clearance in humans. Alcohol. 1998;15(2):147–160.
    1. Levitt M.D., Levitt D.G. Use of a two-compartment model to assess the pharmacokinetics of human ethanol metabolism. Alcohol Clin Exp Res. 1998;22(8):1680–1688.
    1. Lee B.Y., Yoon H.K., Baek I.H., Kwon K.I. Population pharmacokinetics of multiple alcohol intake in humans. Alcohol. 2013;47(2):159–165.
    1. Seng K.Y., Limenta L.M., Heng D., Lee E.J. Population pharmacokinetics and pharmacogenetics of alcohol in Chinese and Indians in Singapore. J Clin Pharm Ther. 2013;38(2):141–149.
    1. Chen Y.C., Peng G.S., Wang M.F., Tsao T.P., Yin S.J. Polymorphism of ethanol-metabolism genes and alcoholism: Correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences. Chem Biol Interact. 2009;178(1-3):2–7.
    1. Crabb D.W., Matsumoto M., Chang D., You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc. 2004;63(1):49–63.
    1. Lieber C.S. Microsomal ethanol-oxidizing system (MEOS): The first 30 years (1968-1998)--a review. Alcohol Clin Exp Res. 1999;23(6):991–1007.
    1. Matsumoto H., Fukui Y. Pharmacokinetics of ethanol: A review of the methodology. Addict Biol. 2002;7(1):5–14.
    1. Lieber C.S. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev. 2004;36(3-4):511–529.
    1. Tsutsumi M., Lasker J.M., Shimizu M., Rosman A.S., Lieber C.S. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology. 1989;10(4):437–446.
    1. Kessova I., Cederbaum A.I. CYP2E1: Biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med. 2003;3(6):509–518.
    1. Lieber C.S. Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta. 1997;257(1):59–84.
    1. Zimatkin S.M., Pronko S.P., Vasiliou V., Gonzalez F.J., Deitrich R.A. Enzymatic mechanisms of ethanol oxidation in the brain. Alcohol Clin Exp Res. 2006;30(9):1500–1505.
    1. Correa M., Salamone J.D. Segovia KN, et al. Piecing together the puzzle of acetaldehyde as a neuroactive agent. Neurosci Biobehav Rev. 2012;36(1):404–430.
    1. Marchitti S.A., Brocker C., Stagos D., Vasiliou V. Non-P450 aldehyde oxidizing enzymes: The aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 2008;4(6):697–720.
    1. Jones A.W. Excretion of alcohol in urine and diuresis in healthy men in relation to their age, the dose administered and the time after drinking. Forensic Sci Int. 1990;45(3):217–224.
    1. Van den Anker J.N. Developmental pharmacology. Dev Disabil Res Rev. 2010;16(3):233–238.
    1. Besunder J.B., Reed M.D., Blumer J.L. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface. Clin Pharmacokinet. 1988;14(4):189–216.
    1. Besunder J.B., Reed M.D., Blumer J.L. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part II) Clin Pharmacokinet. 1988;14(5):261–286.
    1. Funk R.S., Brown J.T., Abdel-Rahman S.M. Pediatric pharmacokinetics: Human development and drug disposition. Pediatr Clin North Am. 2012;59(5):1001–1016.
    1. Signer E., Fridrich R. Gastric emptying in newborns and young infants. Acta Pædiatrica. 1975;64(3):525–530.
    1. Kaye J.L. Review of paediatric gastrointestinal physiology data relevant to oral drug delivery. Int J Clin Pharm. 2011;33(1):20–24.
    1. Martinussen M., Brubakk A.M., Linker D.T., Vik T., Yao A.C. Mesenteric blood flow velocity and its relation to circulatory adaptation during the first week of life in healthy term infants. Pediatr Res. 1994;36(3):334–339.
    1. Friis-Hansen B. Body water compartments in children: Changes during growth and related changes in body composition. Pediatrics. 1961;28(2):169–181.
    1. Murphy, John E., American Society of Health-System Pharmacists . American Society of Health-System Pharmacists; Bethesda, MD: 2008. Clinical pharmacokinetics.
    1. Tayman C., Rayyan M., Allegaert K. Neonatal pharmacology: Extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther. 2011;16(3):170–184.
    1. Pikkarainen P.H., Raiha N.C. Development of alcohol dehydrogenase activity in the human liver. Pediatr Res. 1967;1(3):165–168.
    1. Tran M.N., Wu A.H., Hill D.W. Alcohol dehydrogenase and catalase content in perinatal infant and adult livers: Potential influence on neonatal alcohol metabolism. Toxicol Lett. 2007;169(3):245–252.
    1. Smith M., Hopkinson D.A., Harris H. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet. 1971;34(3):251–271.
    1. Alcorn J., McNamara P.J. Ontogeny of hepatic and renal systemic clearance pathways in infants: Part I. Clin Pharmacokinet. 2002;41(12):959–998.
    1. Vieira I., Sonnier M., Cresteil T. Developmental expression of CYP2E1 in the human liver. hypermethylation control of gene expression during the neonatal period. Eur J Biochem. 1996;238(2):476–483.
    1. Hines R.N., McCarver D.G. The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes. J Pharmacol Exp Ther. 2002;300(2):355–360.
    1. Food and Drug Administration. Drug safety communication: serious health problems seen in premature babies given Kaletra (lopinavir/ritonavir) oral solution. . Accessed 08/14, 2014.
    1. Milsap R.L., Jusko W.J. Pharmacokinetics in the infant. Environ Health Perspect. 1994;102(Suppl 11):107–110.
    1. Rhodin M.M., Anderson B.J., Peters A.M. Human renal function maturation: A quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1):67–76.
    1. Reiter P.D. Neonatal pharmacology and pharmacokinetics. NeoReviews. 2002;3(11):e229–e236.
    1. Rayar P., Ratnapalan S. Pediatric ingestions of house hold products containing ethanol: A review. Clin Pediatr (Phila) 2013;52(3):203–209.
    1. Vogel C., Caraccio T., Mofenson H., Hart S. Alcohol intoxication in young children. J Toxicol Clin Toxicol. 1995;33(1):25–33.
    1. Ragan F.A., Jr, Samuels M.S., Hite S.A. Ethanol ingestion in children. A five-year review. JAMA. 1979;242(25):2787–2788.
    1. Leung A.K. Ethyl alcohol ingestion in children. A 15-year review. Clin Pediatr (Phila) 1986;25(12):617–619.
    1. Fong H.F., Muller A.A. An unexpected clinical course in a 29-day-old infant with ethanol exposure. Pediatr Emerg Care. 2014;30(2):111–113.
    1. Ford J.B., Wayment M.T., Albertson T.E., Owen K.P., Radke J.B., Sutter M.E. Elimination kinetics of ethanol in a 5-week-old infant and a literature review of infant ethanol pharmacokinetics. Case Rep Med. 2013;2013:250716.
    1. McCormick T., Levine M., Knox O. Claudius I. Ethanol ingestion in two infants under 2 months old: A previously unreported cause of ALTE. Pediatrics. 2013;131(2):e604–e607.
    1. Chikwava K., Lower D.R., Frangiskakis S.H., Sepulveda J.L., Virji M.A., Rao K.N. Acute ethanol intoxication in a 7-month-old infant. Pediatr Dev Pathol. 2004;7(4):400–402.
    1. Kvigne V.L., Randall B., Simanton E.G., Brenneman G., Welty T.K. Blood alcohol levels for American Indian mothers and newborns. Pediatrics. 2012;130(4):e1015–e1018.
    1. Burd L., Blair J., Dropps K. Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn. J Perinatol. 2012;32(9):652–659.
    1. Ruz J., Fernandez A., Luque de Castro M.D., Valcarcel M. Determination of ethanol in human fluids--I. determination of ethanol in blood. J Pharm Biomed Anal. 1986;4(5):545–558.
    1. Tagliaro F., Lubli G., Ghielmi S., Franchi D., Marigo M. Chromatographic methods for blood alcohol determination. J Chromatogr. 1992;580(1-2):161–190.
    1. Cordell R.L., Pandya H., Hubbard M., Turner M.A., Monks P.S. GC-MS analysis of ethanol and other volatile compounds in micro-volume blood samples--quantifying neonatal exposure. Anal Bioanal Chem. 2013;405(12):4139–4147.
    1. Geertinger P., Bodenhoff J., Helweg-Larsen K., Lund A. Endogenous alcohol production by intestinal fermentation in sudden infant death. Z Rechtsmed. 1982;89(3):167–172.
    1. Jones A.W., Mardh G., Anggard E. Determination of endogenous ethanol in blood and breath by gas chromatography-mass spectrometry. Pharmacol Biochem Behav. 1983;18(Suppl 1):267–272.
    1. Simic M., Ajdukovic N., Veselinovic I., Mitrovic M., Djurendic-Brenesel M. Endogenous ethanol production in patients with diabetes mellitus as a medicolegal problem. Forensic Sci Int. 2012;216(1-3):97–100.
    1. Jansson-Nettelbladt E., Meurling S., Petrini B., Sjolin J. Endogenous ethanol fermentation in a child with short bowel syndrome. Acta Paediatr. 2006;95(4):502–504.
    1. Zhu L., Baker S.S., Gill C. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology. 2013;57(2):601–609.
    1. Watanabe-Suzuki K., Seno H., Ishii A., Kumazawa T., Suzuki O. Ultra-sensitive method for determination of ethanol in whole blood by headspace capillary gas chromatography with cryogenic oven trapping. J Chromatogr B Biomed Sci Appl. 1999;727(1-2):89–94.
    1. Riley E.P., Infante M.A., Warren K.R. Fetal alcohol spectrum disorders: An overview. Neuropsychol Rev. 2011;21(2):73–80.
    1. Guerri C., Bazinet A., Riley E.P. Foetal alcohol spectrum disorders and alterations in brain and behaviour. Alcohol Alcohol. 2009;44(2):108–114.
    1. de la Monte S.M., Kril J.J. Human alcohol-related neuropathology. Acta Neuropathol. 2014;127(1):71–90.
    1. Katzung B.G., Masters S.B., Trevor A.J. McGraw-Hill Medical; McGraw-Hill distributor; New York; London: 2012. Basic & clinical pharmacology.
    1. Diamond I., Messing R.O. Neurologic effects of alcoholism. West J Med. 1994;161(3):279–287.
    1. Swift R. Direct measurement of alcohol and its metabolites. Addiction. 2003;98(Suppl 2):73–80.
    1. Edenberg H.J. The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30(1):5–13.
    1. Setshedi M., Wands J.R., Monte S.M. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev. 2010;3(3):178–185.
    1. Symposium on Acetaldehyde Related Pathology: Bridging the Trans-Disciplinary Divide, Chadwick, Derek., Goode, Jamie. Novartis Foundation. Acetaldehyde-related pathology: Bridging the trans-disciplinary divide. 2007.
    1. Hamby-Mason R., Chen J.J., Schenker S., Perez A., Henderson G.I. Catalase mediates acetaldehyde formation from ethanol in fetal and neonatal rat brain. Alcohol Clin Exp Res. 1997;21(6):1063–1072.
    1. Maxwell C.R., Spangenberg R.J., Hoek J.B., Silberstein S.D., Oshinsky M.L. Acetate causes alcohol hangover headache in rats. PLoS One. 2010;5(12):e15963.
    1. Gershanik J., Boecler B., Ensley H., McCloskey S., George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med. 1982;307(22):1384–1388.
    1. MacDonald M.G., Getson P.R., Glasgow A.M., Miller M.K., Boeckx R.L., Johnson E.L. Propylene glycol: Increased incidence of seizures in low birth weight infants. Pediatrics. 1987;79(4):622–625.
    1. Allegaert K., Vanhaesebrouck S., Kulo A. Prospective assessment of short-term propylene glycol tolerance in neonates. Arch Dis Child. 2010;95(12):1054–1058.
    1. De Cock R.F., Knibbe C.A., Kulo A. Developmental pharmacokinetics of propylene glycol in preterm and term neonates. Br J Clin Pharmacol. 2013;75(1):162–171.
    1. Salunke S., Brandys B., Giacoia G., Tuleu C. The STEP (safety and toxicity of excipients for paediatrics) database: Part 2 - the pilot version. Int J Pharm. 2013;457(1):310–322.
    1. Turner M.A., Duncan J., Shah U. European study of neonatal exposure to excipients: An update. Int J Pharm. 2013;457(1):357–358.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe